glp-1 medication competitors pharmaceutical companies India's Adoption Lags Despite Cheaper Prices | Nithin Kamath posted on the topic GLP-1 Market Industry Trends and

Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of diabetic nephropathy in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study

If dose de-escalation with a long-acting GLP-1 RA does not result in symptom improvement after 2 weeks, a more aggressive de-escalation approach or medication discontinuation needs to be considered

A brain-only approach can miss important modifiable risks elsewhere in the body

Obviously, the labeling of these meds is still pretty cautious on this, which is understandable, but Id argue that even with this reassuring evidence that we talked about that GLP-1 arent associated with suicide, we should honestly warn any patient about mood changes, depression, or suicidal ideation with any drug and refer them to help ASAP, such as contacting the crisis line at nine hundred eighty eight we mentioned earlier to keep them safe and of course, stop the med if there ever concerns for any of these symptoms